Holen Sie sich die Stockscreener-App
207.19
0.62%
-1.29
Handel nachbörslich:
207.77
0.58
+0.28%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$208.48
Offen:
$208.09
24-Stunden-Volumen:
2.02M
Relative Volume:
0.89
Marktkapitalisierung:
$49.23B
Einnahmen:
$234.31B
Nettoeinkommen (Verlust:
$1.61B
KGV:
31.28
EPS:
6.6243
Netto-Cashflow:
$4.45B
1W Leistung:
+0.82%
1M Leistung:
+4.20%
6M Leistung:
+23.60%
1J Leistung:
+70.67%
1-Tages-Spanne:
$206.22
$211.77
1-Wochen-Bereich:
$201.02
$211.77
52-Wochen-Spanne:
$119.25
$214.93
Cardinal Health Inc Stock (CAH) Company Profile
Firmenname
Cardinal Health Inc
Sektor
Branche
Telefon
(614) 757-3033
Adresse
7000 CARDINAL PLACE, DUBLIN, OH
Vergleichen Sie CAH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
207.19 | 49.53B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
MCK
Mckesson Corporation
|
823.95 | 102.01B | 387.09B | 4.23B | 6.01B | 32.12 |
|
COR
Cencora Inc
|
340.41 | 67.15B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
HSIC
Henry Schein Inc
|
78.14 | 9.25B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.38 | 741.42M | 2.22M | -5.63M | -1.68M | -0.24 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-06-03 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-02-05 | Hochstufung | Jefferies | Hold → Buy |
| 2025-01-08 | Hochstufung | TD Cowen | Hold → Buy |
| 2025-01-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-01-06 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-12-13 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-12-04 | Fortgesetzt | Mizuho | Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-09 | Hochstufung | Argus | Hold → Buy |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-14 | Eingeleitet | Wells Fargo | Underweight |
| 2023-07-10 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-03-31 | Eingeleitet | Citigroup | Neutral |
| 2023-02-03 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-11-04 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-05-26 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-05-18 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-04-12 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-08-06 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-08-05 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-05-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2021-01-08 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-11-02 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-09-25 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-07-20 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-05-15 | Hochstufung | UBS | Neutral → Buy |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-03-20 | Hochstufung | BofA/Merrill | Underperform → Buy |
| 2020-02-12 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-02-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-12-16 | Herabstufung | Guggenheim | Buy → Neutral |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-27 | Herabstufung | Argus | Buy → Hold |
| 2019-08-20 | Hochstufung | Guggenheim | Neutral → Buy |
| 2019-04-18 | Eingeleitet | Guggenheim | Neutral |
| 2019-01-17 | Eingeleitet | UBS | Neutral |
| 2018-11-16 | Herabstufung | Leerink Partners | Outperform → Mkt Perform |
| 2018-04-24 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-04-02 | Hochstufung | Argus | Hold → Buy |
| 2018-03-08 | Eingeleitet | Barclays | Equal Weight |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Underperform |
| 2018-01-05 | Eingeleitet | Evercore ISI | In-line |
Alle ansehen
Cardinal Health Inc Aktie (CAH) Neueste Nachrichten
Cardinal Health (CAH) Laps the Stock Market: Here's Why - Yahoo Finance
Cardinal Health (CAH) Receives a Buy from Bank of America Securities - The Globe and Mail
Cardinal Health, Inc. $CAH Shares Purchased by Robeco Institutional Asset Management B.V. - MarketBeat
Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2026 on February 5 - Cardinal Health
Cardinal Health (CAH) repositions for growth with specialty and services - MSN
Palliative Care Market See Incredible Growth 2025-2032 | - openPR.com
Cardinal Health (CAH) Repositions for Growth with Specialty and Services - Finviz
Cardinal Health's quarterly earnings preview: What you need to know - MSN
Cardinal Health's Quarterly Earnings Preview: What You Need to Know - Barchart.com
User | chroniclejournal.comCardinal Health's Quarterly Earnings Preview: What You Need to Know - FinancialContent
Cardinal Health Ceo Salary Email Address Net Worth Michael Kaufmann Wiki- - shababeek.org
Hennessy Advisors Inc. Sells 4,900 Shares of Cardinal Health, Inc. $CAH - MarketBeat
Diversified Trust Co Decreases Stake in Cardinal Health, Inc. $CAH - MarketBeat
List of 30 Acquisitions by Cardinal Health (Jan 2026) - Tracxn
Traders Purchase High Volume of Call Options on Cardinal Health (NYSE:CAH) - MarketBeat
The Truth About Cardinal Health Inc.: Quiet Stock, Loud Moves – Are You Sleeping On This Play? - AD HOC NEWS
February 2026 Options Now Available For Cardinal Health (CAH) - Nasdaq
Ex-Dividend Reminder: Sysco, Choice Hotels International and Cardinal Health - Nasdaq
Shilanski & Associates Inc. Takes Position in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health, Inc. (NYSE:CAH) Short Interest Down 22.2% in December - MarketBeat
Cardinal Health, Inc. $CAH Shares Sold by Simplify Asset Management Inc. - MarketBeat
U.S. Embolic Protection Devices Market and Competition - GlobeNewswire
U.S. Embolic Protection Devices Market and Competition Analysis, 2025-2033, Featuring Abbott Laboratories, Allium Medical Solutions, Boston Scientific, Cardinal Health and More - Yahoo Finance
Valley National Advisers Inc. Has $97,000 Stock Holdings in Cardinal Health, Inc. $CAH - MarketBeat
Sowell Financial Services LLC Sells 9,987 Shares of Cardinal Health, Inc. $CAH - MarketBeat
Vontobel Holding Ltd. Sells 33,101 Shares of Cardinal Health, Inc. $CAH - MarketBeat
Here's What We Like About Cardinal Health's (NYSE:CAH) Upcoming Dividend - simplywall.st
Why You Might Be Interested In Cardinal Health, Inc. (NYSE:CAH) For Its Upcoming Dividend - Yahoo Finance
Columbus Macro LLC Has $5.73 Million Position in Cardinal Health, Inc. $CAH - MarketBeat
Are Investors Undervaluing Cardinal Health (CAH) Right Now? - Yahoo Finance
Pacer Advisors Inc. Lowers Stock Holdings in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health (FRA:CLH) EV-to-OCF : 10.24 (As of Dec. 25, 2025) - GuruFocus
Cardinal Health, Inc. $CAH Shares Sold by Swedbank AB - MarketBeat
Jim Cramer says “I like Cencora a lot” but notes “Cardinal Health’s got them all beat” - MSN
Here's Why Cardinal Health (CAH) is a Strong Growth Stock - Nasdaq
Cardinal Health Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
The Zacks Analyst Blog Highlights Cardinal Health, Medtronic, Intuitive Surgical and Edwards Lifesciences - The Globe and Mail
Yousif Capital Management LLC Lowers Position in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health (CAH): Evaluating Valuation After Revenue Beat and Growing Optimism in Healthcare Services - Sahm
Cardinal Health (CAH): Rethinking Valuation After a Strong Multi‑Year Share Price Run - Yahoo Finance
Cardinal Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Why Cardinal Health Inc. stock remains a top recommendationWeekly Gains Report & Growth Focused Entry Reports - Улправда
Wedge Capital Management L L P NC Sells 37,487 Shares of Cardinal Health, Inc. $CAH - MarketBeat
Voya Investment Management LLC Has $128.98 Million Stock Holdings in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health, Inc. $CAH Shares Sold by Board of the Pension Protection Fund - MarketBeat
Cardinal Health (CAH) Outperforms Broader Market: What You Need to Know - sharewise.com
Jim Cramer Says "I like Cencora A Lot" But Notes "Cardinal Health's Got Them All Beat" - Finviz
Jim Cramer Says “I like Cencora A Lot” But Notes “Cardinal Health’s Got Them All Beat” - Insider Monkey
Is Cardinal Health Inc. stock positioned well for digital economy2025 Major Catalysts & Weekly Momentum Picks - DonanımHaber
How Cardinal Health Inc. (CLH) stock trades in high volatilityJuly 2025 Pullbacks & Free Safe Entry Trade Signal Reports - DonanımHaber
Cardinal Health (CAH) Continues to Benefit from Rising Demand - Finviz
Finanzdaten der Cardinal Health Inc-Aktie (CAH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.66%
2.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):